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ABSTRACT 
Osteoporosis affects about 10 million people and patients with fragility fractures will in-
crease with the rapid increment in elderly population in Japan. Osteoporosis was defined 
at a 1993 consensus conference as "a systemic skeletal disease characterized by low bone 
mass and micro-architectural deterioration of bone tissue with a resultant increase in fragili-
ty and risk of fracture." Fracture risk depends on age， prior fragility fractures， and bone 
turnover as well as bone mineral density， independently. In Japan， the diagnostic criterion 
for osteoporosis (2000 version) based on bone mineral density and previous fractures is 
used. There are several drugs available which have been proven to prevent fractures. 
豆owever，it is difficult to significantly reduce fracture 1'isk by exercises 01' nut1'itional im-
provements alone without pharmaceutical inte1'vention. Important fields for future research 
in osteoporosis are bone quality evaluation fo1' diagnosis of fracture risk and development 
of powerful new anabolic and antiresorptive agents for t1'eatment. 
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骨折部位 榛骨遠イ立 腫骨 脊椎 大1遺骨頚部
大腿骨頚部 1. 54 1. 71 1. 49 2.37 
手関節 1. 88 1. 71 1. 62 1. 67 
脊椎 1. 73 1. 79 2.06 1. 93 
上腕骨 1. 97 1. 82 1. 78 2.01 
肋骨 1. 43 1. 59 1. 42 1. 56 
骨盤 1. 63 1. 95 1. 74 1. 82 
下腿 2.44 2.00 1. 60 1. 81 
鎖骨 1. 58 1. 57 1. 88 2.01 
膝蓋骨 1. 63 1. 95 1. 67 2.50 
肘関節 1. 45 1. 60 1. 58 1. 68 
足部 1. 43 1. 32 1. 20 1. 21 
鍾部 1. 80 2.17 n.s. 2.06 
大腿骨 1.77 2.16 1. 61 1. 99 
手部 2.05 1. 88 1. 65 1. 79 
足指 1. 50 1. 34 1. 28 1. 27 
手指 1. 40 1. 20 1. 28 1. 34 
足関節部 1. 28 1. 15 n.s. n.s. 















































骨折部位 手関節 椎体 大腿骨頚部 全て
手関節 3.3 (2.0， 5.3) 1.7 (1.4，2.1) 1. 9 (1.6， 2.2) 2.4 (1.7， 3.4) 
椎体 1. 4 (1.2， 1. 7) 4.4 (3.6， 5.4) 2.3 (2.0， 2.8) 1.8 (1.7， 1.9) 
大腿骨頚部 2.5 (1. 8， 3.5) 2.3 (1. 5， 3.7) 1. 9 (NA) 















































































に行われる.診断に際しは，まず胸腰椎の正側 2 として選択する(図 2) .さらに腰椎と大腿骨近
方向のX線撮影を行って，椎体骨折の診断や他の 位部での測定が困難な場合には，前腕や腫骨の測
脊椎疾患の鑑別を行う.特に腰背部痛のため受診 定，またX線フィルムを用いた中手骨骨密度測定
する例には，新鮮脊椎骨折や変形(既存骨折)を (computed X -ray densitometry; CXDやdigital

































表4 主な骨代謝マー力一 ¥ 骨吸収マーカー
デオキシピリジノリン (DPD)(尿)
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of NFK-B ligand (RANKL)は， 1998年にわが国
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